COLUMBIA, Md., Nov. 23, 2020 /PRNewswire/ — Advarra, the market chief in regulatory evaluation options and medical website applied sciences, is happy to announce the acquisition of Longboat, an progressive supplier of medical trial applied sciences centered on website coaching, protocol compliance, and affected person engagement. The addition of Longboat, headquartered in Dublin, Eire, permits Advarra to supply a broader suite of know-how options to websites, biopharmaceutical firms, and medical analysis organizations (CROs) globally, via a site-centric method, driving elevated efficiencies and compliance in medical trials.
“We’re thrilled to hitch forces with Longboat to progress our mutual imaginative and prescient of advancing medical trials and accelerating drug improvement,” stated Gadi Saarony, CEO of Advarra. “By empowering websites and fascinating sufferers via know-how, Longboat creates a pure bridge from our IRB and IBC critiques and consulting providers to our current site-facing know-how options, together with OnCore, our medical trial administration system (CTMS). Collectively, we offer complete choices to facilitate the medical analysis journey, with websites and trial individuals in thoughts. We sit up for welcoming Longboat to Advarra.”
Longboat’s user-friendly, built-in platform helps to simplify trial conduct and participation, enhance research compliance and, in the end, speed up medical trials. Longboat gives research groups with complete oversight of and engagement with websites globally, enabling swift motion to maintain research on monitor. Longboat additionally offers website employees the instruments they should concentrate on affected person care whereas sustaining protocol compliance—an vital regulatory accountability for each websites and sponsors. For sufferers and individuals, Longboat makes their journey simpler from recruitment via trial close-out with capabilities akin to dynamic protocol training instruments, knowledgeable consent, go to reminders and steering, and research updates.
“We’re happy to mix with a high-growth business chief with deep experience in regulatory compliance and website workflow know-how and analytics,” stated Ken O’Connell, CEO of Longboat. “With a dedication to technology-enabled options and an method that fosters collaboration throughout the medical ecosystem, becoming a member of Advarra will present elevated alternatives to broaden compliance administration choices.”
Advarra advances the best way medical analysis is performed: bringing life sciences firms, CROs, analysis websites, investigators, and academia collectively on the intersection of security, know-how, and collaboration. With trusted IRB and IBC evaluation options, progressive applied sciences, skilled consultants, and deep-seated connections throughout the business, Advarra gives built-in options that safeguard sufferers, empower medical websites, guarantee compliance, and optimize analysis efficiency. Advarra is advancing medical trials to make them safer, smarter, and sooner. For extra data, go to advarra.com.
Longboat is an progressive supplier of user-friendly, totally cell medical analysis know-how options that take the complexity out of trials for website employees, sufferers, screens, and research groups, making protocol compliance straightforward and instinctive. With a set of built-in affected person training and engagement options, Longboat gives a superior end-to-end consumer expertise for websites and sufferers, serving to to speed up the drug improvement course of. For extra data, go to longboat.com.